The work in 2018 that small molecules could kill zombie, dysfunctional old senescent cells has led to the creation of many biotech companies working on senescent cells. The drugs used to treat senescent cell are called synolytics. Researchers have shown that senolytics can improve the reparative properties of human heart cells by eliminating senescent "zombie cells," known to be associated with cardiovascular disease and other age-related conditions. Zombie cells release chemicals that can be harmful to nearby cells, affecting cell survival and reparative potential. The build-up of these zombie cells in our bodies promotes aging and age-related conditions, including cardiovascular disease. In lab studies, senolytics have been shown to improve conditions such as cataracts, diabetes, osteoporosis, Alzheimer's disease, heart failure, kidney problems, and age-related loss of muscle. Overall, they have been shown to improve poor physical function and extend health span and life